Can Tumor Cell Migration Be Targeted Therapeutically?
Yes, targeting tumor cell migration is a promising therapeutic strategy. Inhibitors of signaling pathways, such as PI3K inhibitors, have been developed to block the pathways that promote tumor cell migration. Additionally, drugs targeting the ECM components or MMPs are under investigation. Immunotherapy also holds potential by modulating the immune response to target migratory cancer cells.
